Immunohistochemical visualization of the rat vesicular acetylcholine transporter (VAChT) 
regions and in hippocampus, at neuromuscular junctions within skeletal muscle, and in sympathetic and parasympathetic autonomic ganglia and target tissues. Cholinergic nerve terminals contain more VAChT than ChAT immunoreactivity after routine fixation, consistent with a concentration of VAChT within terminal neuronal arborizations in which secretory vesicles are clustered. These include VAChT-positive terminals of the median eminence of the hypothalamus, not observed with ChAT antiserum after routine fixation. Subcellular localization of VAChT in specific organelles in neuronal cells was examined by immunoelectron microscopy in a rat neuronal cell line (PC12-c4) expressing VAChT as well as the endocrine and neuronal forms of the vesicular monoamine transporters (VMAT1 and VMAT2). VAChT is targeted to small synaptic vesicles, while VMAT1 is found mainly but not exclusively on large dense-core vesicles. VMAT2 is found on large dense-core vesicles but not on the small synaptic vesicles that contain VAChT in PC12-c4 cells, despite the presence of VMAT2 immunoreactivity in central and peripheral nerve terminals known to contain monoamines in small synaptic vesicles. Thus, VAChT and VMAT2 may be specific markers for "cholinergic" and "adrenergic" small synaptic vesicles, with the latter not expressed in nonstimulated neuronally differentiated PC12-c4 cells.
Markers for functional presynaptic cholinergic and monoaminergic nerve terminals per se would be useful for the study of cholinergic and monoaminergic synapse formation, loss of synapses in neurodegenerative diseases, and neuroanatomical disposition of synapses throughout the central and peripheral nervous systems. Antibodies against biosynthetic enzymes for acetylcholine (ACh) and monoamines have been used previously for this purpose. However, they are cytosolic proteins that are not specifically concentrated at nerve terminals. Two isoforms of the vesicular monoamine transporter (VMAT) responsible for vesicular uptake of monoamines have been functionally characterized, and antibodies against rat VMAT1 and VMAT2 have previously been used to localize these
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transporters to neuronal and neuroendocrine biogenic aminecontaining cells and in particular their terminal processes (1) (2) (3) (4) (5) (6) .
We have recently cloned and sequenced the rat and human homologs of a putative vesicular acetylcholine (ACh) transporter (VAChT) in Caenorhabditis elegans and Torpedo (7) (8) (9) and demonstrated that the rat VAChT is a functional transporter for ACh (8) . VAChT-encoding mRNA is present in all known major cholinergic cell groups of the central and peripheral nervous systems (8, 10, 11 
MATERIALS AND METHODS
Generation of Anti-VAChT Antisera. The peptide sequence Cys-Glu-Asp-Asp-Tyr-Asn-Tyr-Tyr-Ser-Arg-Ser (CEDDYN-YYSRS in single-letter code), corresponding to the C terminus of rat VAChT, was conjugated through the N-terminal cysteine to keyhole limpet hemocyanin (KLH) and antisera raised in New Zealand White rabbits as described for antibodies generated against C-terminal peptides of rat VMATI and VMAT2 (5) . Sera from rabbits immunized with the KLH-CEDDYNYYSRS conjugate were assayed for anti-VAChT immunoreactivity and specificity by staining of CV-1 cells expressing the rat VAChT cDNA (8) , as described for antibodies against rat VMAT1 and VMAT2 (5 (5) . Cells were then washed and incubated with a secondary antibody conjugated with a 1.4-nm gold probe (Nanoprobe, Stony Brook, NY) followed by silver enhancement (15) .
Immunohistochemistry. Immunohistochemistry for VAChT, VMAT2, ChAT, and tyrosine hydroxylase (TH) was carried out essentially as described for VMAT1 and VMAT2
Ah. Fig. 1 . Staining for either VAChT or ChAT revealed similar numbers of immunoreactive cell bodies in basal forebrain and striatum ( Fig. 1 A and B) . However, VAChT staining of neuronal processes was much more intense than that for ChAT ( Fig. 1 A and B) . VAChT (Fig.  1F) . VAChT-positive cell bodies were also identified in nuclei of the cholinergic ascending reticular activating system and in the medial habenular nucleus, in which VAChT mRNA was previously detected by in situ hybridization histochemistry (11) .
Differential visualization of cholinergic terminals by VAChT and ChAT immunoreactivity was most dramatic in the median eminence. Intense VAChT immunoreactivity in median eminence ( Fig. 2A) (Fig. 3A) . Whether these are collateral or autosynapses or derive from nonmotoneuron cholinergic afferents to the ventral horn is not known. These terminals were not visualized with anti-ChAT, although motor neuron cell bodies were (Fig. 3B) . VAChT immunoreactivity is also concentrated at motor end plates in skeletal muscle relative to ChAT (Fig. 3C) . Staining for VAChT allows visualization of the presynaptic portion of the neuromuscular junction in skeletal muscle in which ChAT immunoreactivity is weak or absent, while ChAT stains motor neuron fibers entering muscle in which VAChT immunoreactivity is weak (Fig. 3D) . Thus, the complementary visualization of nerve fibers and nerve terminals by ChAT and VAChT observed in cholinergic intrinsic and projection neurons of the central nervous system is found in cholinergic motoneurons as well.
The relationship between VAChT and ChAT immunoreactivity in cholinergic neurons within the autonomic nervous system is shown in Fig. 4 . Principal ganglion cells in the superior cervical ganglion are invested with VAChT-positive preganglionic cholinergic nerve terminals (Fig. 4A) . While multiple VAChT-immunoreactive nerve terminals are found on cell bodies in the superior cervical ganglion, ChAT immunoreactivity is relatively stronger in incoming preganglionic cholinergic fibers than in their terminals on principal ganglion cells (Fig. 4B) . Occasional VAChT-positive postganglionic cell bodies are found in superior cervical ganglion of the rat (arrow in Fig. 4A ), in addition to the mainly VMAT2-positive principal ganglion cells (Fig. 4C) (Fig. 5 A and B) . VMAT1 immunoreactivity is present mostly on LDCVs (Fig. 5C ). VMAT1 staining of SSVs (Fig. 5C Inset) VAChT-positive SSV clusters present in the NGF-differentiated PC12-c4 cells (Fig. 6A) (12) . VAChT and ChAT gene expression appears to be tightly linked in mammalian neurons, with both transcripts produced from a common "cholinergic operon" (19) . VAChT is localized here by immunohistochemistry to all known major central and peripheral cholinergic systems identified previously with antibodies directed to ChAT (12, 18, (20) (21) (22) 
